The Business Times

Hong Kong says social media used in 20% of its stock manipulation cases

Published Thu, Sep 24, 2020 · 06:37 AM

[HONG KONG] Hong Kong's financial markets watchdog said on Thursday that about 20 per cent of the market manipulation schemes it is currently investigating are so-called "ramp and dump scams" conducted via social media.

The targets of such scams are local retail investors who account for roughly 10 per cent of Hong Kong-listed shares' trading value, according to exchange data, a relatively high proportion compared to other markets.

Many small cap stocks in Hong Kong are little traded and prone to wild price swings and sudden crashes. The Securities and Futures Commission (SFC), has, in recent years, tried to take a more active role in policing the market.

In the 12 months to end March 2020 it investigated 478 cases of market misconduct, mostly alleged market manipulation or insider dealing.

In a ramp and dump scheme, fraudsters typically purchase a significant portion of shares in a small company with low liquidity, driving up the price.

They then use social media platforms like Facebook, WhatsApp and WeChat to spread favourable, normally false news about the company, sometimes posing as investment experts, drawing more buyers in and allowing the fraudsters to offload their shares.

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

VIEW ALL

Remaining shares are then dumped, causing the price to collapse.

"To avoid falling victim to these scams, the public must be vigilant when offered unsolicited investment advice or tips on social media," SFC chief executive Ashley Alderin said in a statement.

REUTERS

KEYWORDS IN THIS ARTICLE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Capital Markets & Currencies

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here